Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Mylan v. GlaxoSmithKline (Breach of Generic Paxil Agreements)

Pharmaceutical company Mylan claimed that GlaxoSmithKline breached an agreement regarding Mylan’s abbreviated new drug application for paroxetine hydrochloride (“Paxil”) extended-release (ER) tablets. Pursuant to the agreement, Mylan obtained certain intellectual property rights from Glaxo and launched its generic Paxil ER tablets in May 2008. However, Mylan alleged that Glaxo violated the agreement in 2010 when it made a deal with another company to sell generic Paxil. In March 2014, a federal jury awarded Mylan $106.7 million in damages.

Misconduct Type
Intellectual Property
Enforcement Agency
Non-Governmental
Contracting Party
None
Court Type
Civil
Disposition
Judgment Against Defendant
Date of Verdict
3/25/2014
Contractors Involved Penalty
Total
GlaxoSmithKline $106,700,000
Further Information Released
Judgment 4/1/2014
Mylan Press Release 3/27/2014
Amended Complaint 9/12/2011

Federal Contractor Misconduct Database